{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:47:05Z","timestamp":1789519625757,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000292","name":"Cystic Fibrosis Trust","doi-asserted-by":"publisher","award":["CFTP 002"],"award-info":[{"award-number":["CFTP 002"]}],"id":[{"id":"10.13039\/501100000292","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["SMYTH23Q10"],"award-info":[{"award-number":["SMYTH23Q10"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jcf.2024.08.004","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T22:35:46Z","timestamp":1724798146000},"page":"359-363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Infection prevention and control in cystic fibrosis: An update of a systematic review of interventions"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1105-3645","authenticated-orcid":false,"given":"Nicola J","family":"Rowbotham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4143-5364","authenticated-orcid":false,"given":"Sherie","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7836-0151","authenticated-orcid":false,"given":"Nikki","family":"Jahnke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Milczanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9146-8217","authenticated-orcid":false,"given":"Zoe C","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1514-2840","authenticated-orcid":false,"given":"Andrew P","family":"Prayle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5494-5438","authenticated-orcid":false,"given":"Alan R","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2024.08.004_bib0001","unstructured":"Cystic Fibrosis Foundation [US]. Cystic fibrosis foundation patient registry 2022 annual data report. Bethesda, Maryland 2023."},{"key":"10.1016\/j.jcf.2024.08.004_bib0002","series-title":"UK cystic fibrosis registry annual data report 2022","year":"2023"},{"issue":"7","key":"10.1016\/j.jcf.2024.08.004_bib0003","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073513","article-title":"The effect of CFTR modulators on airway infection in cystic fibrosis","volume":"23","author":"Harvey","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"9028","key":"10.1016\/j.jcf.2024.08.004_bib0004","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0140-6736(96)05169-0","article-title":"Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic","volume":"348","author":"Cheng","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jcf.2024.08.004_bib0005","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/17476348.2019.1595594","article-title":"Infection prevention and control in cystic fibrosis: a systematic review of interventions","volume":"13","author":"Rowbotham","year":"2019","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.jcf.2024.08.004_bib0006","series-title":"Infection prevention and control in cystic fibrosis","author":"Rowbotham","year":"2018"},{"key":"10.1016\/j.jcf.2024.08.004_bib0007","unstructured":"Elsevier Science B V. EMBASE: Ovid Technologies."},{"key":"10.1016\/j.jcf.2024.08.004_bib0008","unstructured":"CINAHL Information Systems. CINAHL Plus with Full Text: EBSCO."},{"key":"10.1016\/j.jcf.2024.08.004_bib0009","unstructured":"Wiley Interscience. The Cochrane Library: wiley Interscience; [Available from: http:\/\/www.cochranelibrary.com\/."},{"key":"10.1016\/j.jcf.2024.08.004_bib0010","unstructured":"United States National Library of Medicine. PubMed: United States National Library of Medicine."},{"key":"10.1016\/j.jcf.2024.08.004_bib0011","unstructured":"United States National Library of Medicine. Medline: Ovid Technologies."},{"key":"10.1016\/j.jcf.2024.08.004_bib0012","unstructured":"Clarivate Analytics. Endnote program: wintertree software inc., 2019."},{"key":"10.1016\/j.jcf.2024.08.004_bib0013","unstructured":"Covidence. Covidence systematic review software Melbourne, Australia 2023 [Available from: www.covidence.org."},{"key":"10.1016\/j.jcf.2024.08.004_bib0014","unstructured":"The Grade Working Group. The grading of recommendations assessment, development and evaluation working group [Available from: https:\/\/www.gradeworkinggroup.org\/."},{"issue":"Supplement 1","key":"10.1016\/j.jcf.2024.08.004_bib0015","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1016\/S1569-1993(19)30720-9","article-title":"The CRAFT system (Colour risk assessment folder and treatment system)","volume":"18","author":"MacDuff","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"11","key":"10.1016\/j.jcf.2024.08.004_bib0016","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1002\/ppul.24173","article-title":"Elimination of Australian epidemic strain (AES1) pseudomonas aeruginosa in a pediatric cystic fibrosis center","volume":"53","author":"Kevat","year":"2018","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1016\/j.jcf.2024.08.004_bib0017","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/1757177419872538","article-title":"Incidence and prevalence of common respiratory pathogens before and after implementation of the cystic fibrosis foundation infection prevention and control guideline","volume":"21","author":"Kim","year":"2020","journal-title":"J Infect Prev"},{"key":"10.1016\/j.jcf.2024.08.004_bib0018","series-title":"Face masks reduce the release of pseudomonas aeruginosa cough aerosols when worn for clinically relevant periods","first-page":"1339","author":"Stockwell","year":"2018"},{"issue":"2","key":"10.1016\/j.jcf.2024.08.004_bib0019","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02153-2022","article-title":"Longitudinal effects of elexacaftor\/tezacaftor\/ivacaftor on sputum viscoelastic properties, airway infection and inflammation in patients with cystic fibrosis","volume":"62","author":"Schaupp","year":"2023","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.jcf.2024.08.004_bib0020","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01008-2023","article-title":"Long-term therapy with elexacaftor\/tezacaftor\/ivacaftor (ETI) in cystic fibrosis: improved clinical outcomes but infection and inflammation persist","volume":"62","author":"Tunney","year":"2023","journal-title":"Eur Respir J"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199324008300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199324008300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:14:55Z","timestamp":1778620495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199324008300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1569199324008300"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2024.08.004","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infection prevention and control in cystic fibrosis: An update of a systematic review of interventions","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2024.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}